Luis Barbera-Martin

Oxford University Hospitals NHS Trust

Papers

1

Total Citations

18

H-Index

1

About

Dr. Luis Barbera-Martin is a pioneering surgeon-scientist at the forefront of molecularly targeted intraoperative imaging for prostate cancer. His research centers on the development and clinical translation of novel optical imaging agents that enable real-time, fluorescence-guided surgery. Dr. Barbera-Martin’s most significant contribution is the first-in-human study of the PSMA-targeted minibody IR800-IAB2M, a groundbreaking work that has garnered 18 citations since its 2024 publication. This study demonstrated the feasibility of using a humanized, high-affinity probe to illuminate prostate cancer tissue during robot-assisted laparoscopic radical prostatectomy, offering surgeons unprecedented visual guidance to achieve complete tumor resection while preserving healthy tissue. By bridging preclinical innovation with clinical application, Dr. Barbera-Martin is establishing a new paradigm in precision oncologic surgery. His work not only advances the field of molecular imaging but also holds the potential to reduce positive surgical margins and improve patient outcomes. As a leader in this rapidly evolving domain, his research continues to inspire the integration of targeted fluorescence guidance into standard surgical practice.

Research Focus

Key Achievements

1
H-Index
1
Papers
18
Total Citations
18
Avg Citations/Paper
🏆 Most Cited Paper
First-in-man study of the PSMA Minibody IR800-IAB2M for molecularly targeted intraoperative fluorescence guidance during radical prostatectomy
18 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 27
🏛 Institutions: Oxford University Hospitals NHS Trust

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago